UBS

UBS is keeping the equity blocks market busy in Asia, launching two deals consecutively in the Philippines and Hong Kong — both as sole bookrunner.

A director of UBS' Swiss franc syndicate is leaving the desk and the financial sector on Monday, to pursue a career at a technology start up.

Italian business software vendor TeamSystem returned to the public bond market to refinance a floating rate note it placed privately in 2016, as high yield fund managers increase their demand for floating rate debt this year.

China’s OneSmart International Education Group opened books for its $211.9m IPO of American Depository Shares (ADS) on Monday.

Baidu-backed video streaming platform iQiyi kicked off bookbuilding for its $2.38bn US listing on Monday and was covered quickly.

Two central and eastern European corporates announced euro trades on Friday, adding to a busy pipeline of emerging markets deals.

Books closed on the IPO of Siemens Healthineers, the healthcare technology division of Siemens, on Thursday lunchtime, with the base deal valued at €3.65bn and the company at €28bn.

The day after a jumbo corporate bond issue is often a quiet one for new issuance as investors digest their allocations and assess the impact on secondary spreads. But after Sanofi's €8bn offering on Wednesday, Thursday was another bumper day.

Gategroup, the Swiss airline catering company, has opened the books on its Sfr1.3bn IPO on the SIX Swiss Exchange, valuing the company at Sfr2.6bn at the top of the range.

Petrochemicals company Unigel has set initial price thoughts of 8% for its planned seven year international bond debut. The deal may provide the best indicator yet of how market appetite for Lat Am credit was affected by February’s volatility.

China-based GreenTree Hospitality Group has kicked off bookbuilding for an up to $349.2m IPO on the New York Stock Exchange, according to a filing with the US market regulator.

Up to eight banks in Hong Kong face action over IPO sponsorships, the regulator's head of enforcement revealed this week. UBS is appealing against the suspension of its licence, while ECM bankers are sweating over who will be next. Jonathan Breen and John Loh report.